Corporate news
Grifols' sales rose by 4.6% to Euros 2,741.7 million In 2013 Grifols maintained its position as the third largest producer of plasma derivatives
+ info
+ info
Grifols opens new head office of Araclon Biotech in Zaragoza (Spain) Araclon is an R&D company specializing in immunotherapy and diagnosis of Alzheimer's and other degenerative diseases
+ info
+ info
Vall d'Hebron Research Institute (VHRI) collaborates with Grifols to create a center of excellence for research into alpha 1-antitrypsin deficiency The aim of the project is to improve our understanding of patients with alpha-1-antitrypsin deficiency
+ info
+ info
Highlights
Manufacturing
We are a solid company with an international dimension.
Corporate Commitment
We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.
Martín Villar Haemostasis Awards
Grifols is holding the seventh edition of the Martin Villar Awards for Research in Haemostasis. + info
